Innate Pharma In-Person and Virtual Lacutamab KOL Event: Clinical Perspectives & Market Outlook
| DATE: | October 28, 2025 |
|---|---|
| TIME: | 8:00 AM EDT |
| LOCATION: | Park Terrace Hotel, 18 W 40th St, New York, NY 10018 |
About The Event
Join Innate Pharma for an in-person investor and analyst event to discuss lacutamab, a Phase 3 ready asset.
The program will feature clinical perspectives from the Phase 2 TELLOMAK trial, presented by Pierluigi Porcu, M.D., a world expert in T-cell lymphomas. Innate Pharma’s management will provide updates on the planned Phase 3 trial and the regulatory pathway in CTCL, and, together with industry specialists, will outline the commercial opportunity for lacutamab.
The event will feature live Q&A opportunities.